Trending archive

Every article that has appeared in Trending stays here. Search by title, journal, author or PMID, and narrow by date.

1845 articles

July 202624

Clinical ResearchOncology (Medical)Open access

OPTIM: a randomized phase II trial of nivolumab followed by nivolumab-ipilimumab or docetaxel at progression in recurrent/metastatic squamous cell carcinoma of the head and neck (OPTIM; AIO-KHT-0117).

OPTIM was a randomized phase II trial in adults with platinum-refractory recurrent or metastatic squamous cell carcinoma of the head and neck.

Br J CancerJul 18, 2026Read summary
Case ReportOncology (Medical)

Splenic Granulomatous Lesions Mimicking Metastases on 18 F-FDG PET/CT in a Patient With Ovarian Cancer.

A 76-year-old woman with a history of ovarian cancer underwent 18 F-FDG PET/CT due to increased CA199 levels in routine surveillance.

Clin Nucl MedJul 17, 2026Read case
Clinical ResearchOncology (Medical)

Evaluating the diagnostic performance of exosome biomarkers for the detection of ovarian cancer: a systematic review and meta-analysis.

This systematic review and meta-analysis evaluated the diagnostic performance of exosome biomarkers for ovarian cancer detection, analyzing 16 studies.

Eur J Obstet Gynecol Reprod BiolJul 17, 2026Read summary
Clinical ResearchOncology (Medical)

Anticancer, hepatoprotective, and mechanistic evidence of chlorogenic acid in liver cancer: A systematic review.

This systematic review evaluated the effects of chlorogenic acid (CGA) on liver cancer, analyzing 21 studies. CGA showed anticancer effects in preclinical models by inhibiting tumor cell proliferation and inducing…

Biomed PharmacotherJul 17, 2026Read summary
Clinical ResearchOncology (Medical)Open access

Disease Stabilization with MEK Inhibitors in NF1-Associated Plexiform Neurofibromas: A Systematic Review and Meta-Analysis with Subgroup Analyses by Age and Study Design.

This systematic review and meta-analysis evaluated the efficacy and safety of MEK inhibitors in 769 patients with NF1-associated plexiform neurofibromas (PN).

CNS DrugsJul 17, 2026Read summary
Case ReportOncology (Medical)

Recurrent Metastatic Esthesioneuroblastoma: First-in-human α/β PRRT With Actinium-225/Lutetium-177-DOTA-LM3 SSTR Antagonist Achieving Partial Response After Failure of Lutetium-177-DOTATOC PRRT.

A 45-year-old woman with recurrent metastatic esthesioneuroblastoma, previously treated and symptomatic, received a novel peptide receptor radionuclide therapy (PRRT) using a somatostatin receptor antagonist labeled…

Clin Nucl MedJul 17, 2026Read case
Case ReportOtolaryngology (ENT)

The laryngofissure approach for near-infrared photoimmunotherapy in laryngeal cancer: A novel larynx-preservation strategy.

A 67-year-old male with laryngeal cancer presented with hoarseness and was staged as cT2N2bM0, Stage IVA. After two years of concurrent chemoradiotherapy, he experienced local recurrence in the subglottic and posterior…

Auris Nasus LarynxJul 17, 2026Read case
Clinical ResearchOncology (Medical)

Survival Outcomes of Head and Neck Neuroendocrine Carcinoma: A Systematic Review.

This systematic review examined survival outcomes in patients with head and neck neuroendocrine carcinoma (HNNEC), focusing on tumor characteristics and treatment strategies.

Head NeckJul 17, 2026Read summary
Clinical ResearchHematologyOpen access

Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.

The FELIX study evaluated the efficacy of obecabtagene autoleucel (obe-cel) in adults with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) compared to historical controls.

LeukemiaJul 17, 2026Read summary
Clinical ResearchOncology (Medical)

A Phase 2 Trial of Intravesical Cabazitaxel, Gemcitabine, and Cisplatin for the Treatment of Nonmuscle-Invasive Bacillus Calmette-Guérin-Unresponsive Urothelial Carcinoma of the Bladder.

This single-center phase 2 trial evaluated sequential intravesical cabazitaxel, gemcitabine, and cisplatin in patients with BCG-unresponsive high-risk nonmuscle-invasive bladder cancer who refused or were ineligible for…

J UrolJul 17, 2026Read summary
Clinical ResearchHematology

Safety and efficacy of immune checkpoint inhibitors as a bridge to allogeneic hematopoietic stem cell transplantation in classical Hodgkin lymphoma: A systematic review and meta-analysis.

This systematic review and meta-analysis evaluated the safety and efficacy of immune checkpoint inhibitors (ICIs) as a bridge to allogeneic hematopoietic stem cell transplantation (allo-HCT) in patients with classical…

Transpl ImmunolJul 16, 2026Read summary
Clinical ResearchGastroenterology

Artificial intelligence-assisted detection and optical differentiation of colorectal lesions in Lynch syndrome surveillance (CADLY2): a multicentre, open-label, randomised controlled superiority trial.

The CADLY2 trial evaluated the impact of computer-aided detection (CADe) on adenoma detection rates during surveillance colonoscopy in patients with Lynch syndrome.

Lancet Gastroenterol HepatolJul 16, 2026Read summary
Clinical ResearchOncology (Medical)

Pesticide exposure and all health outcomes: An umbrella review of meta-analyses of observational studies.

This umbrella review systematically analyzed 53 meta-analyses of observational studies to evaluate the health outcomes associated with pesticide exposure.

J Hazard MaterJul 16, 2026Read summary
Clinical ResearchHematologyOpen access

Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results.

This phase 1 trial evaluated the long-term safety and efficacy of asciminib in 48 patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia (CML-CP).

LeukemiaJul 16, 2026Read summary
Clinical ResearchOncology (Medical)

Impacts of oncological treatments on fertility: A systematic review.

This systematic review evaluated the impact of oncological treatments on fertility using murine models, analyzing 30 studies.

Reprod ToxicolJul 16, 2026Read summary
Clinical ResearchOncology (Medical)

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

This systematic review and meta-analysis compared patient-derived xenografts (PDX) and patient-derived organoids (PDO) in predicting treatment response in cancer patients.

Cancer Treat RevJul 16, 2026Read summary
Clinical ResearchGastroenterology

Comparison of long-term outcomes between liver transplantation and liver resection for intrahepatic cholangiocarcinoma: An updated systematic review and meta-analysis.

This systematic review and meta-analysis evaluated long-term outcomes of liver transplantation (LT) versus liver resection (LR) for intrahepatic cholangiocarcinoma (ICC) in 5478 patients.

Surg OncolJul 16, 2026Read summary
Clinical ResearchOncology (Medical)

Impact of palliative intervention on end-of-life outcomes for patients undergoing surgery for cancer.

This randomized controlled trial examined the impact of early palliative care on end-of-life outcomes in 235 patients undergoing curative surgery for abdominal cancer.

SurgeryJul 16, 2026Read summary
Clinical ResearchOncology (Medical)

Phase I Dose-Escalation Study Combining Irinotecan-Loaded Drug-Eluting Bead Chemoembolization with Yttrium-90 Glass Microsphere Radioembolization in Colorectal Liver Metastases (DEBIR 90 Y).

This Phase I dose-escalation study evaluated the maximum tolerated dose (MTD) of yttrium-90 glass microspheres combined with irinotecan-loaded drug-eluting beads in patients with colorectal liver metastases.

J Vasc Interv RadiolJul 16, 2026Read summary
Clinical ResearchOncology (Medical)Open access

Integrated Evaluation of Survival, Surgical Conversion, and Toxicity for Induction Therapy in Initially Unresectable Colorectal Liver Metastases: An Individual Patient Data Network Meta-analysis.

This network meta-analysis evaluated the efficacy of induction therapies for initially unresectable colorectal cancer liver metastases (CRLM) using individual patient data from seven randomized controlled trials…

Ann Surg OncolJul 16, 2026Read summary
Clinical ResearchOncology (Medical)Open access

Dose-reduced (24 Gy) involved-site radiotherapy combined with rituximab in early-stage non-gastric mucosa-associated lymphoid tissue lymphoma: a prospective phase II trial.

This prospective phase II trial evaluated the efficacy of 24 Gy involved-site radiotherapy combined with rituximab in 60 patients with early-stage non-gastric mucosa-associated lymphoid tissue lymphoma.

LeukemiaJul 16, 2026Read summary
Clinical ResearchOncology (Medical)Open access

A Prospective, Multicenter Randomized Controlled Trial (RCT) of the da Vinci SP ® Surgical System versus Open Surgery in Nipple-Sparing Mastectomy (NSM) Procedures for Patients with Breast Cancer.

This multicenter randomized controlled trial compared robotic-assisted nipple-sparing mastectomy (rNSM) using the da Vinci SP® system to open nipple-sparing mastectomy (NSM) in women with early-stage breast cancer.

Ann Surg OncolJul 16, 2026Read summary
Clinical ResearchOncology (Medical)Open access

Thermal ablation versus liver resection for small colorectal liver metastases (≤ 3 cm): a systematic review and meta-analysis of randomized and propensity score-matched studies.

This systematic review and meta-analysis evaluated thermal ablation versus liver resection for small colorectal liver metastases (CRLM ≤ 3 cm) using data from seven studies.

Surg EndoscJul 16, 2026Read summary
Clinical ResearchOncology (Medical)

Direct tumour-adipocyte contact / Stroma AReactive Invasion Front Area (TAC/SARIFA) predicts adverse outcome in colorectal cancer: a focused evidence synthesis and meta-analysis.

This focused evidence synthesis and meta-analysis assessed whether direct tumour-adipocyte contact, termed TAC/SARIFA, is associated with survival in colorectal cancer.

HistopathologyJul 16, 2026Read summary

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.